Biotechnology Avalo Therapeutics’ Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades – Avalo Therapeutics (NASDAQ:AVTX) Read more
Biotechnology Bristol Myers Squibb’s Acquired Adagrasib Combo Therapy May Benefit Colorectal Cancer Patients With Certain Mutation – Bristol-Myers Squibb (NYSE:BMY) Read more